ANGLE (LSE:AGL) Research & Development : £0.00 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is ANGLE Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. ANGLE's Research & Development for the six months ended in Dec. 2023 was £0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was £0.00 Mil.

ANGLE Research & Development Historical Data

The historical data trend for ANGLE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ANGLE Research & Development Chart

ANGLE Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

2.34

3.66

3.44

4.49

ANGLE Semi-Annual Data
	Apr14	Oct14	Apr15	Oct15	Apr16	Oct16	Apr17	Oct17	Apr18	Oct18	Apr19	Oct19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

ANGLE Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.00 Mil.

ANGLE (LSE:AGL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

ANGLE Research & Development Related Terms

Thank you for viewing the detailed overview of ANGLE's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

ANGLE (LSE:AGL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » ANGLE PLC (LSE:AGL) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

ANPCY:USA ANPCF:USA DWV:Germany

Address

10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF

Website

https://www.angleplc.com

ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which majority of its revenue is generated from Europe.